Is 5.6C the Emperor of the World?

3min Snip

00:00

Play full episode

Summary

Transcript

Episode notes

5.6C: The depth of knowledge, particularly on the science side, was one of the things that actually drew me to make an investment with you. You can't indoctrinate in any way, except you can accept them. I don't think it's responsible to tell people to do psychedelics, but maybe I would say start reading. He says he used to be a lot more rational and quantity; now he listens to his "gut" A new partner has joined 5.6C who is even more knowledgeable about psychedelic pharmaceuticals than him.

Brom Rector is the founder of Empath Ventures, a VC fund that in invests in early-stage psychedelics startups. Prior to founding Empath, Brom sent several years as a portfolio manager and quantitative researcher. Brom joins the show to discuss the current state of the psychedelics industry, the lessons learned founding a VC fund, the differences between psychedelics and cannabis, and a whole lot more. Important Links:

Show Notes:

How Brom became interested in psychedelic investing
Psychedelics and the mental health epidemic
Depoliticising psychedelics
Empath Ventures’ business model
How we can scientifically improve psychedelics
The influence of hippie culture
A contrarian view on Big Pharma
The potential benefits of ibogaine
The differences between cannabis and psychedelics
Do some people not react to psychedelics?
Brom’s thoughts on microdosing
Lessons learned from founding a VC company
The benefits of Rule 506(c)

Books Mentioned:

How to Change Your Mind: What the New Science of Psychedelics Teaches Us About Consciousness, Dying, Addiction, Depression, and Transcendence; by Michael Pollan
Healing Back Pain: The Mind-Body Connection; by John E. Sarno MD